Home Newsroom Contacts Profile Website Mail & Guardian
Breaking news
Fine acquisition for Imperial

[Johannesburg, 10 October 2014] - This acquisition is in line with Imperial's strategy to integrate pharmaceutical wholesaling into its service offering, in order to offer an unrivalled route to market proposition for clients in this sector, comments Imperial Health Sciences managing director Dr Iain Barton.

"Fine Pharmaceuticals, led by Makhosi Sibanda, provides a route to market solution for pharmaceutical, over-the-counter and front shop brand owners targeting the growing retail pharmacy and hospital markets in the region," he states.

"In keeping with Imperial's preferred approach of partnering with local businesses and entrepreneurs, in order to grow its African footprint and augment its service offering, Makhosi and his team retain a sizeable equity stake in Fine Pharmaceuticals," Barton adds.
[Full Story.]
What's new
   Imperial is supply chain educator of the year
   Imperial supports SANParks’ honorary rangers
   Imperial Managed Logistics wins Tiger Brands distribution contract
Editorial highlights
Fine acquisition for Imperial

Last updated : 10 October 2014


Home  |   Newsroom  |   Contacts  |   Profile  |   Imperial Logistics  |   Mail & Guardian